G70.89 ICD-10-CM Code: Other specified myoneural disorders
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the nervous system (G00-G99) / Diseases of myoneural junction and muscle (G70-G73)
G70.89
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceOther specified myoneural disorders
Other rare disorders affecting the connection between nerves and muscles that do not fit into the more specific myoneural disorder categories.
Buddy Insight
Other specified myoneural disorders captures neuromuscular junction conditions that do not fit into the more precisely defined categories.
CMS-HCC V28
MappedHCC 196
RAF 0.402
CMS-HCC V24
MappedHCC 75
RAF 0.425
ACA/HHS
00
RAF 0
ESRD/PACE
MappedHCC 75
RAF 0.0
RXHCC
MappedHCC 153
RAF 0.0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for G70.89 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for G70.89 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for G70.89 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for G70.89 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for G70.89 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for G70.89 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for G70.89 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is G70.89 an HCC code?
Yes. G70.89 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre under the CMS-HCC V28 risk adjustment model (and Myasthenia Gravis/Myoneural Conditions and Guillain-Barre Syndrome under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G70.89
For G70.89to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G70.89 during that encounter, not just copy-forwarded from a problem list.
What This Code Means
G70.89 is the ICD-10-CM diagnosis code for other specified myoneural disorders. Other rare disorders affecting the connection between nerves and muscles that do not fit into the more specific myoneural disorder categories. G70.89 sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering diseases of myoneural junction and muscle (g70-g73).
Under the CMS-HCC V28 risk adjustment model, G70.89 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre (HCC 196) with a community, non-dual, aged base RAF weight of 0.402. Under the older CMS-HCC V24 model, G70.89 maps to Myasthenia Gravis/Myoneural Conditions and Guillain-Barre Syndrome (HCC 75) with a community, non-dual, aged base RAF weight of 0.425. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code only after confirming the condition does not fit G70.0-G70.81. Because G70.89 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G70.89 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
Clinical Significance
Other specified myoneural disorders captures neuromuscular junction conditions that do not fit into the more precisely defined categories. While a residual code, it still represents significant neuromuscular disease requiring specialized management. Proper documentation and code capture ensure that patients with these rare conditions are appropriately represented in risk adjustment.
Documentation Requirements
- ✓Description of the specific myoneural disorder in the clinical record
- ✓Clinical findings: pattern of weakness, fatigability, response to treatment
- ✓Electrodiagnostic studies supporting neuromuscular junction dysfunction
- ✓Documentation explaining why the condition does not fit into more specific G70 categories
- ✓Treatment plan and current management
- ✓Provider's explicit diagnosis of the specific myoneural condition
Commonly Confused Codes
- •G70.00/G70.01 — Myasthenia gravis has its own specific codes; do not use G70.89 for myasthenia gravis
- •G70.80/G70.81 — Lambert-Eaton syndrome has specific codes that should be used when that condition is diagnosed
- •G70.9 — Myoneural disorder, unspecified is even less specific; use G70.89 when the provider specifies the condition
- •G70.1 — Toxic myoneural disorders should be used when a toxic cause is identified